ProQuant

Curated by Signal

Provider of a proteomics platform for drug discovery

Overview

Provider of a proteomics platform for drug discovery. It offers a proprietary platform for performing LC-MS bottom-up proteomics on a wide range of biological samples, delivering precision unachievable by other proteomics platforms.

Key facts

Founded: 2022
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

5 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Gentle Recovery
Provider of exercise and yoga programs for cancer rehabilitation
Health TechnologyUnited Kingdom
UcanBe
AI-driven health span technology to analyze health data of elders
Health TechnologyLondon, United Kingdom
My Pharmacy
Online pharmacy offering prescription medicines
Health TechnologyGreat Harwood, United Kingdom

About ProQuant

What does ProQuant do?

Provider of a proteomics platform for drug discovery.

Where is ProQuant headquartered?

ProQuant is headquartered in Cambridge, United Kingdom.

When was ProQuant founded?

ProQuant was founded in 2022.

Which sector is ProQuant in?

ProQuant operates in Health Technology.

Who are ProQuant's competitors?

Companies similar to ProQuant include Gentle Recovery, UcanBe, and My Pharmacy.